GATA4 and hepatocellular carcinoma: In HCC, heterozygous loss of GATA4 is frequent (68%, n = 366, Fig. 3a; Table 1) and inactivating mutations in ARID1A are common (44%, n = 366, Fig. 4a; Table 1)6.